Paytient’s Innovative Payment Solutions Earn Top Recognition in 2025

Paytient’s Innovative Payment Solutions Earn Top Recognition in 2025.jpg

Paytient, a leader in healthcare affordability and payment solutions, was recognized with Modern Healthcare’s 2025 Best in Business Award in the Patient Experience and Engagement category.

The award underscores Paytient’s role as a critical infrastructure partner for insurers and employers, helping bridge the gap between health coverage and access, particularly through the company’s Medicare Prescription Payment Plan (M3P), which now serves nearly half of the market.


2025: A Watershed Year

Paytient experienced rapid adoption across both commercial and regulated lines of business, driven by rising deductibles, increased healthcare costs, and demand for personalized payment solutions. Key highlights include:

“This award acknowledges that affordability is the critical missing link in modern benefit design,” said Brian Whorley, Founder and CEO of Paytient. “We are honored by this recognition, which affirms our partnership with forward-thinking employers and insurers. Together, we are ensuring that no member has to choose between their physical health and financial security.”


Redefining the Currency of Care

For self-funded employers and commercial health plans, Paytient embeds a flexible payment layer directly into health plans, giving employees control over their care. Key results reported in 2025 include:


About Paytient

Paytient empowers individuals to access care interest-free and without fees, bridging the gap between coverage and cost. Over 6,000 employers and insurers offer Paytient, providing more than $2 billion in healthcare purchasing power directly to members.

For more information, visit www.paytient.com.


Forward-looking information is subject to risks and uncertainties. Read full DISCLAIMER.

Join our Mailing List

Sign up and receive carefully curated updates on our latest stock picks, investment recommendations, company spotlights, and in-depth market analysis.

Name

By submitting your information, you’re giving us permission to email you. No spam, no excessive emails. You may unsubscribe at any time.